CHF87.00
2.11% today
SIX Swiss Exchange, Jul 23, 02:08 pm CET
ISIN
CH0386200239
Symbol
MED

Medartis Stock price

CHF85.20
+9.30 12.25% 1M
+15.40 22.06% 6M
+28.60 50.53% YTD
+14.10 19.83% 1Y
+5.70 7.17% 3Y
+45.20 113.00% 5Y
+23.24 37.51% 10Y
+23.24 37.51% 20Y
SIX Swiss Exchange, Closing price Tue, Jul 22 2025
-0.60 0.70%
ISIN
CH0386200239
Symbol
MED

Key metrics

Basic
Market capitalization
CHF1.2b
Enterprise Value
CHF1.2b
Net debt
positive
Cash
CHF138.7m
Shares outstanding
12.4m
Valuation (TTM | estimate)
P/E
274.8 | 66.4
P/S
5.2 | 4.4
EV/Sales
5.2 | 4.4
EV/FCF
55.3
P/B
4.3
Financial Health
Equity Ratio
58.6%
Return on Equity
1.3%
ROCE
1.8%
ROIC
3.5%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
CHF224.8m | CHF266.6m
EBITDA
CHF29.5m | CHF45.7m
EBIT
CHF7.2m | CHF19.5m
Net Income
CHF3.5m | CHF15.9m
Free Cash Flow
CHF21.0m
Growth (TTM | estimate)
Revenue
6.1% | 18.6%
EBITDA
-5.0% | 8.3%
EBIT
-13.1% | 170.3%
Net Income
469.4% | 351.0%
Free Cash Flow
1,693.2%
Margin (TTM | estimate)
Gross
79.5%
EBITDA
13.1% | 17.1%
EBIT
3.2%
Net
1.6% | 6.0%
Free Cash Flow
9.3%
More
EPS
CHF0.3
FCF per Share
CHF1.7
Short interest
-
Employees
883
Rev per Employee
CHF250.0k
Show more

Is Medartis a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,028 stocks worldwide.

Medartis Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Medartis forecast:

5x Buy
71%
2x Hold
29%

Analyst Opinions

7 Analysts have issued a Medartis forecast:

Buy
71%
Hold
29%

Financial data from Medartis

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
225 225
6% 6%
100%
- Direct Costs 46 46
4% 4%
21%
179 179
7% 7%
79%
- Selling and Administrative Expenses 141 141
6% 6%
62%
- Research and Development Expense 43 43
66% 66%
19%
30 30
5% 5%
13%
- Depreciation and Amortization 22 22
2% 2%
10%
EBIT (Operating Income) EBIT 7.23 7.23
13% 13%
3%
Net Profit 3.53 3.53
469% 469%
2%

In millions CHF.

Don't miss a Thing! We will send you all news about Medartis directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medartis Stock News

AD HOC NEWS
7 days ago
Medartis Holding AG / CH0386200239
AD HOC NEWS
7 days ago
Medartis Holding AG / CH0386200239

Company Profile

Medartis Holding AG engages in the development, manufacture, and sale of medical devices for surgical fixation of bone fractures. It operates through the following geographical segments: EMEA, US, APAC, and LATAM. The company was founded by Thomas Straumann on November 3, 1997 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Matthias Schupp
Employees 883
Founded 1997
Website www.medartis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today